Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1483]

Ultrasound activation in cancer immunotherapy

Ultrasound activation in cancer immunotherapy

ASCO 2023: Personalised vaccines may revolutionise cancer treatment

ASCO 2023: Personalised vaccines may revolutionise cancer treatment

‘Smart drugs’ give new hope to some patients with advanced pancreatic cancer

‘Smart drugs’ give new hope to some patients with advanced pancreatic cancer

ASCO 2023: Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location

ASCO 2023: Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location

ASCO 2023: Alternate response criteria may allow early outcome prediction in pancreatic neuroendocrine tumours

ASCO 2023: Alternate response criteria may allow early outcome prediction in pancreatic neuroendocrine tumours

NCCN joins collaboration to improve standards in cancer care for vietnam

NCCN joins collaboration to improve standards in cancer care for vietnam

ASCO 2023: Minimally invasive surgery is an effective treatment option for early-stage pancreatic cancer

ASCO 2023: Minimally invasive surgery is an effective treatment option for early-stage pancreatic cancer

Cancers in distant organs alter liver function

Cancers in distant organs alter liver function

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

ASCO 2023: Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumours

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer

More from ecancer